These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 27631130)

  • 1. Niclosamide is a Negative Allosteric Modulator of Group I Metabotropic Glutamate Receptors: Implications for Neuropathic Pain.
    Ai N; Wood RD; Yang E; Welsh WJ
    Pharm Res; 2016 Dec; 33(12):3044-3056. PubMed ID: 27631130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
    Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group III metabotropic glutamate receptors inhibit hyperalgesia in animal models of inflammation and neuropathic pain.
    Goudet C; Chapuy E; Alloui A; Acher F; Pin JP; Eschalier A
    Pain; 2008 Jul; 137(1):112-124. PubMed ID: 17900808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red nucleus glutamate facilitates neuropathic allodynia induced by spared nerve injury through non-NMDA and metabotropic glutamate receptors.
    Yu J; Ding CP; Wang J; Wang T; Zhang T; Zeng XY; Wang JY
    J Neurosci Res; 2015 Dec; 93(12):1839-48. PubMed ID: 26373546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of morphine antiallodynic efficacy by ACPT-III, a group III metabotropic glutamate receptor agonist, in rat spinal nerve ligation-induced neuropathic pain.
    Lee HG; Park SK; Yoon MH
    Pharmacol Biochem Behav; 2010 Jul; 96(1):108-13. PubMed ID: 20434481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Nitazoxanide as a Group I Metabotropic Glutamate Receptor Negative Modulator for the Treatment of Neuropathic Pain: An In Silico Drug Repositioning Study.
    Ai N; Wood RD; Welsh WJ
    Pharm Res; 2015 Aug; 32(8):2798-807. PubMed ID: 25762088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new metabotropic glutamate receptor agonist with in vivo anti-allodynic activity.
    Stanley NJ; Hutchinson MR; Kvist T; Nielsen B; Mathiesen JM; Bräuner-Osborne H; Avery TD; Tiekink ER; Pedersen DS; Irvine RJ; Abell AD; Taylor DK
    Bioorg Med Chem; 2010 Aug; 18(16):6089-98. PubMed ID: 20638290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-selective mechanisms of negative allosteric modulators binding to group I metabotropic glutamate receptors.
    Fu TT; Tu G; Ping M; Zheng GX; Yang FY; Yang JY; Zhang Y; Yao XJ; Xue WW; Zhu F
    Acta Pharmacol Sin; 2021 Aug; 42(8):1354-1367. PubMed ID: 33122823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 attenuates neuropathic pain by epigenetic regulation of mGluR1/5 expressions in type 2 diabetic rats.
    Zhou CH; Zhang MX; Zhou SS; Li H; Gao J; Du L; Yin XX
    Pain; 2017 Jan; 158(1):130-139. PubMed ID: 27749604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and biological evaluation of tetrahydrothieno[2,3-c]pyridine derivatives as selective metabotropic glutamate receptor 1 antagonists for the potential treatment of neuropathic pain.
    Nam M; Kim T; Kwak J; Seo SH; Ko MK; Lim EJ; Min SJ; Cho YS; Keum G; Baek DJ; Lee J; Pae AN
    Eur J Med Chem; 2015 Jun; 97():245-58. PubMed ID: 25984841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal metabotropic glutamate receptor 4 is involved in neuropathic pain.
    Wang H; Jiang W; Yang R; Li Y
    Neuroreport; 2011 Mar; 22(5):244-8. PubMed ID: 21358553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.
    Chen Y; Nong Y; Goudet C; Hemstapat K; de Paulis T; Pin JP; Conn PJ
    Mol Pharmacol; 2007 May; 71(5):1389-98. PubMed ID: 17303702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The glutamatergic system as a target for neuropathic pain relief.
    Osikowicz M; Mika J; Przewlocka B
    Exp Physiol; 2013 Feb; 98(2):372-84. PubMed ID: 23002244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group II metabotropic glutamate receptor antagonism prevents the antiallodynic effects of R-isovaline.
    Asseri KA; Puil E; Schwarz SK; MacLeod BA
    Neuroscience; 2015 May; 293():151-6. PubMed ID: 25701709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of peripheral metabotropic glutamate receptors in bee venom-induced nociception and inflammation in conscious rats.
    Chen HS; Qu F; He X; Kang SM; Liao D; Lu SJ
    J Pain; 2010 Apr; 11(4):321-9. PubMed ID: 19853520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.
    Rodriguez AL; Nong Y; Sekaran NK; Alagille D; Tamagnan GD; Conn PJ
    Mol Pharmacol; 2005 Dec; 68(6):1793-802. PubMed ID: 16155210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
    Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
    Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.
    Anighoro A; Graziani D; Bettinelli I; Cilia A; De Toma C; Longhi M; Mangiarotti F; Menegon S; Pirona L; Poggesi E; Riva C; Rastelli G
    Bioorg Med Chem; 2015 Jul; 23(13):3040-58. PubMed ID: 26014480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral group I metabotropic glutamate receptor activation leads to muscle mechanical hyperalgesia through TRPV1 phosphorylation in the rat.
    Chung MK; Lee J; Joseph J; Saloman J; Ro JY
    J Pain; 2015 Jan; 16(1):67-76. PubMed ID: 25451626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.